| Literature DB >> 27364493 |
Jon Gitz Holler1, Daniel Pilsgaard Henriksen2, Søren Mikkelsen3, Lars Melholt Rasmussen4, Court Pedersen5, Annmarie Touborg Lassen6.
Abstract
BACKGROUND: The knowledge of the frequency and associated mortality of shock in the emergency department (ED) is limited. The aim of this study was to describe the incidence, all-cause mortality and factors associated with death among patients suffering shock in the ED.Entities:
Keywords: Epidemiology; Incidence; Mortality; Shock
Mesh:
Year: 2016 PMID: 27364493 PMCID: PMC4929750 DOI: 10.1186/s13049-016-0280-x
Source DB: PubMed Journal: Scand J Trauma Resusc Emerg Med ISSN: 1757-7241 Impact factor: 2.953
In-hospital characteristics of shock (2000–2011)
| Overall mortality, n (%) | ||||
|---|---|---|---|---|
| Specialty/Department | n (%) | Duration of admission in days (mean) | 7-days | 90-days |
| Emergency Department | 605 (36.8) | 0.3 | 125 (20.7) | 203 (33.6) |
| General Internal Medicine | 169 (10.3) | 8.6 | 52 (30.8) | 81 (47.9) |
| Cardiology | 160 (9.7) | 5.7 | 44 (27.5) | 71 (44.4) |
| Gastroenterology | 134 (8.1) | 9.1 | 27 (20.2) | 45 (33.6) |
| Geriatriology | 118 (7.2) | 10.1 | 24 (20.3) | 64 (54.2) |
| General Surgery | 98 (6.0) | 9.0 | 23 (23.5) | 46 (46.9) |
| Orthopedic Surgery | 55 (3.3) | 13.7 | 9 (16.4) | 20 (36.4) |
| Pulmonology | 53 (3.2) | 10.2 | 14 (26.4) | 27 (50.9) |
| Endocrinology | 50 (3.0) | 6.8 | 10 (20.0) | 23 (46.0) |
| Infectious Diseases | 47 (2.9) | 9.5 | 12 (25.5) | 21 (44.7) |
| Heart, Pulmonary and vascular Surgery | 44 (2.7) | 8.9 | 17 (38.6) | 22 (50.0) |
| Neurology | 41 (2.5) | 18.5 | 9 (22.0) | 13 (31.7) |
| Nephrology | 17 (1.0) | 4.4 | 7 (41.2) | 10 (58.8) |
| Hematology | 10 (0.6) | 13.3 | 2 (20.0) | 4 (40.0) |
| Rheumatology | 10 (0.6) | 13.8 | 0 (0.0) | 4 (40.0) |
| Oncology | 8 (0.5) | 6.8 | 2 (25.0) | 4 (50.0) |
| Urology | 8 (0.5) | 9.1 | 1 (12.5) | 4 (50.0) |
| Otorhinolaryngology | 6 (0.4) | 5.7 | 0 (0.0) | 0 (0.0) |
| Neurosurgery | 5 (0.3) | 12.2 | 2 (40.0) | 3 (60.0) |
| Plastic Surgery | 5 (0.3) | 17.2 | 0 (0.0) | 2 (40.0) |
| Hospice | 3 (0.2) | 28.0 | 0 (0.0) | 3 (100.0) |
| Total | 1.646 (100.0) | 5.9 | 380 (23.1) | 670 (40.7) |
Prehospital and in-hospital characteristics of shock (2007–2011)
| MECU, n (%)* | Overall mortality, n (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Specialty/Department | ED contacts, n (%) | Prehospital contacts, n (%) | Intravenous fluid therapy | Intravenous vasopressor therapy | Mechanical ventilation | Cardiac arrest | ICU admission, n (%) | 7-days | 90-days |
| Emergency Department | 209 (27.0) | 39 (18.7) | 16 (7.7) | 17 (2.8) | 10 (4.8) | 4 (1.9) | 9 (4.3) | 47 (22.5) | 70 (33.5) |
| General Internal Medicine | 36 (5.0) | 2 (5.6) | 1 (2.8) | 1 (0.6) | 1 (2.8) | 1 (2.8) | 14 (38.9) | 10 (27.8) | 14 (38.9) |
| Cardiology | 79 (10.0) | 19 (24.1) | 11 (13.9) | 11 (6.9) | 12 (15.2) | 10 (12.7) | 22 (27.9) | 26 (32.9) | 40 (50.6) |
| Gastroenterology | 74 (9.0) | 11 (14.9) | 6 (8.1) | 7 (5.2) | 4 (5.4) | 0 (0.0) | 18 (24.3) | 14 (18.9) | 27 (36.5) |
| Geriatriology | 81 (10.0) | 17 (21.0) | 5 (6.2) | 4 (3.4) | 5 (6.2) | 2 (2.5) | 3 (3.7) | 16 (19.8) | 43 (53.1) |
| General Surgery | 53 (7.0) | 5 (9.4) | 3 (5.7) | 5 (5.1) | 1 (1.9) | 1 (1.9) | 18 (34.0) | 14 (26.4) | 26 (49.1) |
| Orthopedic Surgery | 35 (4.0) | 4 (11.4) | 3 (8.6) | 3 (5.5) | 0 (0.0) | 0 (0.0) | 8 (22.9) | 6 (17.1) | 13 (37.1) |
| Pulmonology | 53 (7.0) | 12 (22.6) | 11 (20.8) | 11 (20.8) | 6 (11.3) | 2 (3.8) | 16 (30.2) | 14 (26.4) | 27 (50.9) |
| Endocrinology | 29 (4.0) | 2 (6.9) | 1 (3.5) | 1 (2.0) | 0 (0.0) | 0 (0.0) | 3 (10.3) | 2 (6.9) | 9 (31.0) |
| Infectious Diseases | 47 (6.0) | 17 (36.2) | 8 (17.0) | 9 (19.2) | 5 (10.6) | 0 (0.0) | 25 (53.2) | 12 (25.5) | 21 (44.7) |
| Heart, Pulmonary and vascular Surgery | 23 (3.0) | 5 (21.7) | 4 (17.4) | 5 (11.4) | 2 (8.7) | 0 (0.0) | 12 (52.2) | 8 (34.8) | 9 (39.1) |
| Neurology | 17 (2.0) | 2 (15.4) | 4 (23.53) | 4 (9.8) | 2 (11.8) | 0 (0.0) | 7 (41.2) | 1 (5.9) | 2 (11.8) |
| Nephrology | 13 (2.0) | 8 (47.1) | 1 (7.7) | 1 (9.8) | 0 (0.0) | 0 (0.0) | 4 (30.8) | 6 (46.2) | 8 (61.5) |
| Hematology | 4 (1.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (25.0) | 0 (0.0) | 0 (0.0) |
| Rheumatology | 10 (1.0) | 1 (10.0) | 1 (10.0) | 1 (10.0) | 1 (10.0) | 0 (0.0) | 2 (20.0) | 0 (0.0) | 4 (40.0) |
| Oncology | 6 (1.0) | 2 (33.3) | 1 (16.7) | 1 (12.5) | 0 (0.0) | 0 (0.0) | 1 (16.7) | 2 (33.3) | 4 (66.8) |
| Urology | 2 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (12.5) | 1 (50.0) |
| Otorhinolaryngology | 5 (1.0) | 0 (0.0) | 0 (0.0) | 1 (16.7) | 0 (0.0) | 0 (0.0) | 1 (20.0) | 0 (0.0) | 0 (0.0) |
| Neurosurgery | 5 (1.0) | 4 (80.0) | 4 (80.0) | 4 (80.0) | 3 (60.0) | 1 (20.0) | 5 (100.0) | 2 (40.0) | 3 (60.0) |
| Plastic Surgery | 2 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (50.0) |
| Hospice | 1 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (100.0) |
| Total | 784 (100.0) | 150 (19.1) | 80 (10.2) | 42 (5.4) | 52 (6.6) | 21 (2.7) | 169 (21.6) | 180 (23.0) | 323 (41.2) |
ED emergency department, ICU intensive care unit, MECU Physician-staffed mobile emergency care units
*Data on MECU transportation and ICU admission available from 2007 to 2011
Fig. 1Flow chart of patients recruited to the study
Baseline characteristics at time of arrival to the EDa
| Variable | Total (%) |
|---|---|
| N (%) | 1,646 (100 %) |
| Age in years, Median (IQR) | 71 (56–80) |
| Sex (%) | |
| Male | 885 (53.8 %) |
| Female | 761 (46.2 %) |
| Age in age groups, yr (%) | |
| 18–39 | 146 (8.9 %) |
| 40–64 | 496 (30.1 %) |
| 65–84 | 745 (45.3 %) |
| 85+ | 259 (15.7 %) |
| Charlson Comorbidity Index (%) | |
| 0 | 495 (30.1 %) |
| 1 | 627 (38.1 %) |
| >2 | 524 (31.8 %) |
| Vital variables | |
| Systolic blood pressure, Median (IQR) | 88 (80–94) |
| Diastolic blood pressure, Median (IQR) | 53 (44–62) |
| Heart rate, Median (IQR) | 100 (85–114) |
| Shock Index (SI), n (%) | |
| SI, Median (IQR) | 1.2 (1.0–1.3) |
| SI ≤0.7 | 94 (5.9) |
| 0.7> SI ≤1 | 267 (16.6 %) |
| SI >1.0 | 1,245 (77.5 %) |
| Number of organ failures, n (%) | |
| 1 | 1,155 (70.2 %) |
| 2 | 389 (23.6 %) |
| 3+ | 114 (6.2 %) |
| Site of organ failure (%) | |
| Cardiovascular | 1,245 (76.6 %) |
| Renal | 382 (23.2 %) |
| Coagulation | 545 (33.1 %) |
| Hepatic | 78 (4.7 %) |
aValues expressed as total number (fraction) and medians [25 percentile-75 percentile] as appropriate
Fig. 2Annual incidence rate during 2000–2011. The crude annual incidence rates of shock from 2000 to 2011 and the standardized incidence rate to the population of the EDs cathment area in 2000 (using direct standardization on sex and ten-year age bands). Bars indicate the 95 % confidence interval based on a Poisson distribution
Fig. 3Estimated incidence rates stratified by sex and age group from 2000 to 2011. Incidence rates estimated on the basis of a Poisson model adjusting for sex, age group, interaction between sex and age group, and calendar years. The table is showing the corresponding estimated incidence rate ratios with 95 % confidence intervals (95 % CI)
Prognostic factors of death in patients presenting with shock at presentation to the ED – Cox regression
| 0–7 days | 8–90 days | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| N, total (%) | N, died (%) | Crude HR (95 % CI) |
| Adjusted HR (95 % CI) a |
| N, died (%) | Crude HR (95 % CI) |
| Adjusted HR (95 % CI) a |
| |
| Gender | |||||||||||
| Female (reference) | 761 (46.2) | 167 (21.9) | 1 | 1 | 133 (22.4) | 1 | 1 | ||||
| Male | 885 (53.8) | 213 (24.1) | 1.12 (0.91–1.37) | 0.289 | 1.10 (0.90–1.35) | 0.354 | 157 (23.4) | 1.05 (0.83–1.32) | 0.686 | 1.03 (0.82–1.30) | 0.813 |
| Age (continous) | 1.03 (1.03–1.04) | <0.001 | 1.03 (1.03–1.04) | <0.001 | 1.04 (1.04–1.05) | <0.001 | 1.04 (1.03–1.05) | <0.001 | |||
| Comorbidity level | |||||||||||
| 0 (reference) | 495 (30.1) | 95 (19.2) | 1 | 1 | 53 (13.3) | 1 | 1 | ||||
| 1 to 2 | 627 (38.1) | 134 (21.4) | 1.13 (0.87–1.47) | 0.372 | 0.85 (0.65–1.11) | 0.229 | 106 (21.5) | 1.71 (1.23–2.37) | 0.001 | 1.23 (0.88–1.71) | 0.229 |
| >2 | 524 (31.8) | 151 (28.8) | 1.56 (1.21–2.02) | 0.001 | 1.10 (0.85–1.43) | 0.470 | 131 (22.9) | 3.06 (2.22–4.20) | <0.001 | 2.03 (1.47–2.80) | <0.001 |
| Number of organ failures | |||||||||||
| 1 (reference) | 1,155 (70.2) | 206 (17.8) | 1 | 1 | 189 (19.9) | 1 | 1 | ||||
| 2 | 389 (23.6) | 126 (32.4) | 1.96 (1.57–2.44) | <0.001 | 1.90 (1.53–2.38) | <0.001 | 85 (32.3) | 1.78 (1.37–2.30) | <0.001 | 1.76 (1.36–2.28) | <0.001 |
| 3+ | 102 (6.2) | 48 (47.1) | 3.08 (2.25–4.22) | <0.001 | 3.13 (2.28–4.30) | <0.001 | 16 (29.6) | 1.67 (1.00–2.79) | 0.048 | 1.75 (1.05–2.92) | 0.033 |
aCox proportional hazard model adjusted for sex, age as a continuous variable, Charlson comorbidity level (0, 1–2, >2) and number of organ failures. Patients who died during the first 7 days after admission were excluded from the analyses of 8- to 90-day mortality
Fig. 4Kaplan-Meier curves illustrating overall 90-day survival according to age (a), Charlson comorbidity index (b), organ failures (c) and systolic blood pressure levels (d). Below the curves are listed the number at risk at corresponding intervals in survival time